Test Price
4,000 AED✅ Home Collection Available
Liquid Biopsy 117-Gene Panel in UAE | 4,000 AED
Executive Summary & Core Metrics
Test Overview & Methodology
The Liquid Biopsy 117-Gene Panel is a cutting-edge next-generation sequencing (NGS) assay that analyses circulating tumor DNA (ctDNA) from a single blood draw. It identifies clinically actionable mutations across 117 cancer-associated genes, enabling non-invasive cancer diagnostics, real-time monitoring, and personalized therapy selection.
| Feature | Our Test (Liquid Biopsy 117 Panel) | Closest Alternative (Tissue Biopsy Gene Panel) |
|---|---|---|
| Methodology | NGS (Illumina®) – high-depth ctDNA sequencing | NGS on FFPE tissue – limited by tumour cellularity |
| Genes Covered | 117 comprehensive cancer genes | Variable (40–150 genes), often incomplete |
| Turnaround Time | 25 Working Days | 28–35 Working Days |
| Sample Collection | Streck Tube home blood draw – non‑invasive | Invasive surgical biopsy – risk of complications |
| Clinical Utility | Diagnosis, therapy selection, dynamic monitoring | Snapshot of single lesion; may miss heterogeneity |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA License: 61713011 – “Facing a potential cancer diagnosis is never easy, but the Liquid Biopsy 117-Gene Panel offers you a precise, non‑invasive window into your genomic landscape. It empowers your oncology team to tailor treatment and monitor progression with far less physical strain. Please remember that this test must always be correlated with your clinical history, imaging, and specialist evaluation.”
Advisory: Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion & Emergency Red Flags
- This test is not indicated for surgical fitness certification, routine prenatal screening, or travel health documentation.
- Not for individuals under 18 without explicit legal guardian consent, in compliance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- If you experience sudden, severe pain, uncontrolled bleeding, acute neurological changes (e.g., seizures, confusion), or signs of sepsis (fever, rapid heartbeat), proceed to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What does the Liquid Biopsy 117-Gene Panel test for and who should consider it?
A: The panel detects clinically significant mutations across 117 cancer-related genes from a simple blood sample. It is recommended for patients with confirmed or suspected solid tumours, those undergoing targeted therapy monitoring, and individuals with hereditary cancer syndromes who need non‑invasive surveillance. The results guide precision oncology decisions with actionable genomic insights.
2. How is the sample collected and what preparation is required?
A: A certified phlebotomist collects a single Streck tube blood sample from your home, following a strict cold-chain protocol. No fasting or special preparation is needed; continue your regular medications unless your doctor advises otherwise. The collection takes less than ten minutes and is scheduled at your convenience between 8 AM and 11 PM.
3. How long do results take and how will I receive them?
A: Final validated results are delivered in 25 working days via a secure electronic health portal with telephonic clinical guidance. Your referring physician receives the comprehensive molecular report, and our genetic counsellors are available to explain findings and implications in plain language.
UAE Regulatory & Data Privacy Adherence
- Strictly adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability ensuring diagnostic accuracy and patient safety.
- Data privacy protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health data handling complies with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Laboratory certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) for quality management.
- Test methodology aligned with DHA and MOHAP regulatory standards.
Clinical & Logistical Metadata
| Test Name | Liquid Biopsy 117-Gene Panel |
| Price (AED) | 4,000 AED |
| Turnaround Time | 25 Working Days |
| Sample Type / Matrix | Whole Blood (Streck Tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina® |
| ICD-10-CM Code | Z85.9 |
| LOINC Code | 95007-5 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians